Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.8K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diallyl trisulfide sensitizes radiation therapy on glioblastoma through directly targeting thioredoxin 1.

Free radical biology & medicine·2022
Same author

Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion.

Proceedings of the National Academy of Sciences of the United States of America·2022
Same author

Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China.

Vaccines·2022
Same author

Comprehensive Therapy for Infant Vascular Tumor Associated With Kasabach-Merritt Phenomenon-Single-Center Primary Experience.

Frontiers in pediatrics·2022
Same author

Dynamic tripartite construct of interregional engram circuits underlies forgetting of extinction memory.

Molecular psychiatry·2022
Same author

Influence of Dietary Salt Intake on T2D Treatment.

Frontiers in endocrinology·2022

Related Experiment Video

Updated: Sep 30, 2025

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
11:31

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate

Published on: October 31, 2012

16.0K

CD73+ adipose-derived stem cells reduce scar formation through PLOD1.

Miao Xu1, Shuo Fang2, Xiaorong Ma1

  • 1Department of Plastic and Reconstructive Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Annals of Translational Medicine
|March 14, 2022
PubMed
Summary

Adipose-derived mesenchymal stem cells (AMSCs) expressing CD73 show improved wound healing by reducing fibrosis. This occurs through decreased procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 (PLOD1) levels, suggesting CD73+ AMSCs are more effective for scar reduction.

Keywords:
CD73Scar formationadipose-derived mesenchymal stem cells (AMSCs)procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 (PLOD1)

More Related Videos

Author Spotlight: Advancements in Stem Cell Regenerative Therapy Through Photobiomodulation
05:42

Author Spotlight: Advancements in Stem Cell Regenerative Therapy Through Photobiomodulation

Published on: April 5, 2024

1.1K
Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model
08:06

Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model

Published on: August 4, 2017

11.5K

Related Experiment Videos

Last Updated: Sep 30, 2025

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
11:31

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate

Published on: October 31, 2012

16.0K
Author Spotlight: Advancements in Stem Cell Regenerative Therapy Through Photobiomodulation
05:42

Author Spotlight: Advancements in Stem Cell Regenerative Therapy Through Photobiomodulation

Published on: April 5, 2024

1.1K
Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model
08:06

Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model

Published on: August 4, 2017

11.5K

Area of Science:

  • Regenerative Medicine
  • Stem Cell Therapy
  • Dermatology

Background:

  • Cutaneous scar formation is a key factor in assessing skin wound healing success.
  • Adipose-derived mesenchymal stem cells (AMSCs) show therapeutic potential for wound healing.
  • Suppression of procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 (PLOD1) in AMSCs reduces scarring, potentially via macrophage polarization modulation.

Purpose of the Study:

  • To investigate if a CD73-positive (CD73+) subpopulation of AMSCs reduces scar formation more effectively than CD73-negative (CD73-) AMSCs.
  • To explore the role of PLOD1 levels in CD73+ versus CD73- AMSCs concerning scar reduction.

Main Methods:

  • Gene profiling of CD73+ and CD73- AMSCs from a public database (GSE167219).
  • Isolation and flow cytometry sorting of CD73+ and CD73- AMSCs from mouse adipose tissue.
  • Manipulation of PLOD1 levels in AMSCs (depletion via sh-PLOD1 or overexpression via transgene) and transplantation into induced skin injuries in mice to assess fibrosis.

Main Results:

  • CD73+ AMSCs exhibited significantly lower PLOD1 levels compared to CD73- AMSCs.
  • Transplantation of CD73+ AMSCs resulted in reduced skin injury site fibrosis compared to CD73- AMSCs.
  • Restoring PLOD1 in CD73+ AMSCs negated the anti-fibrosis effect, while PLOD1 depletion in CD73- AMSCs improved fibrosis outcomes.

Conclusions:

  • CD73+ AMSCs represent a subpopulation with enhanced therapeutic efficacy in wound healing.
  • These cells inhibit scar formation indirectly through reduced PLOD1 expression.
  • The findings highlight the potential of targeting CD73+ AMSCs for improved scar management.